Maintenance Infos

Publications for Arenas-Pinto, A

Navigate back| Up a level
Export as
Group by:
Jump to:
Number of items: 4.


Wright, E J; Grund, B; Robertson, K R; Cysique, L; Brew, B J; Collins, G L; Poehlman-Roediger, M; Vjecha, M J; Penalva de Oliveira, A C; Standridge, B; Carey, C; Avihingsanon, A; Florence, E; Lundgren, J D; Arenas-Pinto, A; Mueller, N J; Winston, A; Nsubuga, M S; Lal, L; Price, R W; INSIGHT START, Neurology Substudy Group (2018). No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts. AIDS, 32(8):985-997.


Antinori, Andrea; Clarke, Amanda; Svedhem-Johansson, Veronika; Arribas, José R; Arenas-Pinto, Alejandro; Fehr, Jan; Gerstoft, Jan; Horban, Andrzej; Clotet, Bonaventura; Ripamonti, Diego; Girard, Pierre-Marie; Hill, Andrew M; Moecklinghoff, Christiane (2015). Week 48 efficacy and central nervous system analysis of darunavir/ritonavir monotherapy versus darunavir/ritonavir with two nucleoside analogues. AIDS, 29(14):1811-1820.


Arenas-Pinto, Alejandro; Weller, Ian; Ekong, Rosemary; Grant, Alison; Karstaedt, Alan; Reiss, Peter; Telisinghe, Lilanganee; Weber, Rainer; Bolhaar, Martine; Bradman, Neil; Ingram, Catherine (2012). Common inherited mitochondrial DNA mutations and nucleoside reverse transcriptase inhibitor-induced severe hyperlactataemia in HIV-infected adults: an exploratory study. Antiviral Therapy, 17(2):275-82.


Arenas-Pinto, A; Grant, A; Bhaskaran, K; Copas, A; Carr, A; Worm, S W; Martinez, E; Reiss, P; Dunn, D; Weber, R; Hoy, J; Weller, I (2011). Risk factors for fatality in HIV-infected patients with dideoxynucleoside-induced severe hyperlactataemia or lactic acidosis. Antiviral Therapy, 16(2):219-226.

This list was generated on Fri Sep 21 04:38:46 2018 CEST.